SecBot SecBot
SECBOTREPLAY Home › Report › RDY

RDY · Dr

DR REDDYS LABORATORIES LTD · 6-K filed May 15, 2026 at 15:55 ET

At the news

BULLISHIMPACT 6/10

6-K filed May 15, 2026 at 15:55 ET

Dr. Reddy's launched its generic Semaglutide Injection in Canada on May 15, 2026, following Health Canada approval on April 28, 2026. The company is the first to receive approval for a generic semaglutide in Canada, which is also the first G7 country to authorize the product. This expands Dr. Reddy's GLP-1 portfolio and demonstrates its ability to rapidly commercialize complex peptides.

  • Dr. Reddy's launched generic Semaglutide Injection in Canada on May 15, 2026.
  • Health Canada Notice of Compliance (NOC) received on April 28, 2026.
  • Dr. Reddy's is the first company to receive Health Canada approval for generic Semaglutide Injection.
  • Canada is the first G7 country to grant market authorization for generic Semaglutide Injection.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access